Back to Search
REENA RAZDAN, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1699353649Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
PMID 19679411·Drug Alcohol Depend·2009
7-preclinical
Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke.
PMID 19255856·J Neuroimmune Pharmacol·2009
6-review
The endogenous brain constituent N-arachidonoyl L-serine is an activator of large conductance Ca2+-activated K+ channels.
PMID 18923087·J Pharmacol Exp Ther·2009
7-preclinical
Impact of etofenprox (Vectron 20 WP) indoor residual spray on malaria transmission.
PMID 19675390·Indian J Med Res·2009
4-observational
Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods.
PMID 19428438·Steroids·2009
4-observational
Synthesis and pharmacological activity of a potent inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol.
PMID 19266526·ChemMedChem·2009
7-preclinical
N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.
PMID 18682568·J Pharmacol Exp Ther·2008
7-preclinical
Posterior reversible encephalopathy syndrome following a cesarean delivery: case report and literature review.
PMID 18593061·Conn Med·2008
5-case
Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury.
PMID 18304750·Neuroscience·2008
7-preclinical
Multiple pathways involved in the biosynthesis of anandamide.
PMID 17631919·Neuropharmacology·2008
7-preclinical
Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice.
PMID 18622177·Behav Pharmacol·2008
7-preclinical
Significance of cannabinoid CB1 receptors in improgan antinociception.
PMID 17644043·J Pain·2007
7-preclinical
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
PMID 17245363·Br J Pharmacol·2007
7-preclinical
The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
PMID 17245367·Br J Pharmacol·2007
4-observational
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model.
PMID 17245417·J Cereb Blood Flow Metab·2007
7-preclinical
The role of fluorine substitution in the structure-activity relationships (SAR) of classical cannabinoids.
PMID 17257842·Bioorg Med Chem Lett·2007
7-preclinical
Efficacy of PermaNet 2.0 against Anopheles culicifacies and Anopheles stephensi, malaria vectors in India.
PMID 17847857·J Am Mosq Control Assoc·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 150 BERGEN ST # UHI-248
NEWARK, NJ 07103 - Phone
- (972) 972-6056
Quick Facts
- NPI
- 1699353649
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile